Unimed Innovation is managing externally financed clinical trials at St. Olavs hospital (Trondheim University Hospital), Levanger hospital and Namsos hospital. These hospitals are all parts of the Central Norway Regional Health Authority. On behalf of these hospitals, we are responsible for study contracts and budgeting, as well as the financial control from the start until completion of the study.
The company is owned by Fondsstiftelsen at St. Olavs hospital.
Unimed Innovation operates in close cooperation with the Department of Research and Development at St. Olavs hospital, and is managed by the Operating Room of the Future.
Research Coordinator Ingrid Granbo
Phone: +47 932 23 788
What is a clinical trial?
Clinical trials are scientific investigations exploring whether a medical strategy, treatment or device is safe and effective for human use. These studies may also show which medical approaches work best for various diseases. Clinical trials produce evidence that helps patients and their health-care providers to make better health-related decisions (evidence based medicine).
Participants in a clinical trial contribute to medical science by providing valuable knowledge about potential treatment modalities and methods of prevention. Participants with an illness or disease have the possibility to receive the most up to date treatment, getting care and attention from the clinical trial staff, while at the same time helping other patients.
Studies are divided into two main categories based on their funding:
- Funded studies
The Clinical study is initiated by an external party covering all study costs, also called Industry Sponsored Studies. The external party is the sponsor (responsible for the study and owner of the data).
- Partly funded studies
Investigator initiated clinical studies which receive financial contribution covering parts of the study costs. The investigator/hospital is the sponsor (responsible for the study and owner of the data).
Our role in clinical trials
After the preparation with the contract and budget process, we follow the clinical trial from the contract is signed until the study is finished. During the whole study we represent the link between the company and the project manager/hospital.
- Contract and financial negotiations with the company, based on the study protocol and associated resource requirements for implementation of the study
- Contact with the various service departments, such as laboratory and radiology service, collecting price estimates and setting up the study budget
- Finalizing and signing of main contract together with the external company
- Sub-contracts with internal departments at the hospital
- Financial control and follow-up during the study; including invoicing, project accounting and reporting
- Filing essential documents for completed studies (15 years according to GCP)
When new studies are planned at the hospitals, it is important that we are involved as soon as possible by the company and the project manager.
Invoice Address and Bank Information
Invoice address and postal address
Unimed Innovation AS
Olav Kyrres gt. 10
All invoices must be marked with reference number (M-number). Please contact us if you need this.
Organisation (VAT) number: NO 989 376 748 MVA
Bank account number: 8601 1874 578
Bank name and address: Danske Bank, 7466 Trondheim, Norway
IBAN: NO32 8601 1874 578
Clinical trials are subject to VAT. Invoices include VAT to Norwegian companies, but not to foreign companies.
Read more about Unimed Innovation in Norwegian